Studies in Amino-Acid Uptake by RD3 Sarcoma Cell Suspensions in Vitro
1955

Amino Acid Uptake by RD3 Sarcoma Cells

publication Evidence: moderate

Author Information

Author(s): G. Wiseman, F. N. Ghadially

Primary Institution: University of Sheffield

Hypothesis

Understanding the mechanism of amino acid uptake by neoplastic tissue may enable the suppression of tumor growth while leaving normal tissue unaffected.

Conclusion

The study found that RD3 sarcoma cells can concentrate amino acids against a gradient, with methionine being a strong inhibitor of other amino acids' uptake.

Supporting Evidence

  • The RD3 sarcoma cells concentrated L-histidine, L-proline, L-ornithine, L-lysine, and L-methionine.
  • L-methionine completely inhibited the concentration of L-ornithine and L-lysine.
  • The study demonstrated a mechanism for active concentration of amino acids in neoplastic cells.

Takeaway

The researchers studied how cancer cells take in amino acids, finding that some amino acids can block the uptake of others, which might help control tumor growth.

Methodology

The study involved preparing a suspension of RD3 sarcoma cells and measuring their ability to concentrate various amino acids in vitro.

Limitations

The technical difficulties of maintaining high concentrations of diamino-acids in circulation over a prolonged period may hinder further investigation.

Participant Demographics

The study used RD3 sarcoma cells derived from albino rats.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication